跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,877 条关于
“LUTATHERA (lutetium Lu 177 dotatate)”
全部
2,877
临床试验
1,471
药物
919
机构
16
资讯
471
4个月前
Curium Knocks Out Novartis Cancer Drug Patents in Generics Fight
6个月前
Lantheus Receives FDA Tentative Approval for First Generic Version of LUTATHERA for Neuroendocrine Tumors
前天
FDA Approves Curium's Bexlutry, First Generic Radioligand, Challenging Lutathera's GEP-NET Monopoly
2年前
Eli Lilly Acquires Point Biopharma for $1.4 Billion to Expand Radioligand Therapy Portfolio
3个月前
St. Bernards Becomes First in Northeast Arkansas to Offer LUTATHERA Targeted Radiotherapy for Rare Neuroendocrine Tumors
去年
Neuroendocrine Tumor Pipeline Shows Strong Growth with 75+ Therapies in Development
去年
Lutetium Lu 177 Dotatate Shows Promise in Metastatic Bronchopulmonary Neuroendocrine Tumors
9个月前
Lutetium Lu 177 Dotatate Demonstrates Significant Efficacy in Advanced Intracranial Meningioma Phase 2 Trial
7个月前
Neuroendocrine Tumor Pipeline Shows Promise with 75+ Therapies in Development and Recent FDA Approvals
3年前
Nanopharmaceutics Completes Enrollment in Phase 2 Neuroendocrine Tumor Study Combining Triapine with Lutetium Lu 177 Dotatate
第 1 页，共 48 页
上一页
下一页
